These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5317 related articles for article (PubMed ID: 3910610)

  • 1. Echinomycin: the first bifunctional intercalating agent in clinical trials.
    Foster BJ; Clagett-Carr K; Shoemaker DD; Suffness M; Plowman J; Trissel LA; Grieshaber CK; Leyland-Jones B
    Invest New Drugs; 1985; 3(4):403-10. PubMed ID: 3910610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of echinomycin (NSC 526417), a bifunctional intercalating agent, administered by 24-hour continuous infusion.
    Kuhn JG; Von Hoff DD; Hersh M; Melink T; Clark GM; Weiss GR; Coltman CA
    Eur J Cancer Clin Oncol; 1989 May; 25(5):797-803. PubMed ID: 2737217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of echinomycin.
    Pazdur R; Haas CD; Baker LH; Leichman CG; Decker D
    Cancer Treat Rep; 1987 Dec; 71(12):1217-9. PubMed ID: 3690532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Baker VV; Barnhill DR; Adelson MD
    Am J Clin Oncol; 1990 Aug; 13(4):299-301. PubMed ID: 2198794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Malfetano J
    Am J Clin Oncol; 1990 Jun; 13(3):191-3. PubMed ID: 2346124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new antitumor agent: methyl sulfonium perchlorate of echinomycin.
    Park YS; Kim YH; Kim SK; Choi SJ
    Bioorg Med Chem Lett; 1998 Apr; 8(7):731-4. PubMed ID: 9871531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer.
    Wadler S; Tenteromano L; Cazenave L; Sparano JA; Greenwald ES; Rozenblit A; Kaleya R; Wiernik PH
    Cancer Chemother Pharmacol; 1994; 34(3):266-9. PubMed ID: 8004762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885.
    Chang AY; Tu ZN; Bryan GT; Kirkwood JM; Oken MM; Trump DL
    Invest New Drugs; 1994; 12(2):151-3. PubMed ID: 7860234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed biosynthesis of novel derivatives of echinomycin by Streptomyces echinatus. I. Effect of exogenous analogues of quinoxaline-2-carboxylic acid on the fermentation.
    Gauvreau D; Waring MJ
    Can J Microbiol; 1984 Apr; 30(4):439-50. PubMed ID: 6744120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of echinomycin administered on an intermittent bolus schedule.
    Harvey JH; McFadden M; Andrews WG; Byrne PJ; Ahlgren JD; Woolley PV
    Cancer Treat Rep; 1985 Dec; 69(12):1365-8. PubMed ID: 4075312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assay.
    Cobb WR; Bogden AE; Reich SD; Griffin TW; Kelton DE; LePage DJ
    Invest New Drugs; 1983; 1(1):5-9. PubMed ID: 6678856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activity of echinomycin in a human tumor cloning system.
    Lathan B; Von Hoff DD
    Cancer Drug Deliv; 1984; 1(3):191-8. PubMed ID: 6544121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641.
    Schilsky RL; Faraggi D; Korzun A; Vogelzang N; Ellerton J; Wood W; Henderson IC
    Invest New Drugs; 1991 Aug; 9(3):269-72. PubMed ID: 1783527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signaling cascade in DNA bisintercalator, echinomycin-induced apoptosis of HT-29 cells: evidence of the apoptotic process via activation of the cytochrome c-ERK-caspase-3 pathway.
    Park JY; Ryang YS; Shim KY; Lee JI; Kim HS; Kim YH; Kim SK
    Int J Biochem Cell Biol; 2006 Feb; 38(2):244-54. PubMed ID: 16214385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the toxicity and antiblastoma activity of antibiotics echinomycin and 6270 in complexes with DNA].
    Bazhanov VS; Gol'dberg LE; Berdnikova VV; Shepelevtseva NG; Dudnik IuV
    Antibiotiki; 1977 Apr; 22(4):357-61. PubMed ID: 578090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of echinomycin on DNA methylation.
    Adams RL; Rinaldi A
    FEBS Lett; 1987 May; 215(2):266-8. PubMed ID: 3582654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of echinomycin to deoxyribonucleic acid.
    Wakelin SP; Waring MJ
    Biochem J; 1976 Sep; 157(3):721-40. PubMed ID: 985413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 266.